PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PanGenomic Health, a precision health company, is set to file its overdue audited annual financial statements and related documents by June 28, 2024, following a delay caused by payment issues with its auditors. The delay also affected the filing of its interim financial reports, which are expected to be submitted shortly after the annual documents. During this period, the company’s CEOs and CFOs are restricted from trading company securities until the filings are completed and the Management Cease Trade Order by the BCSC is lifted.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.